---
schema_version: "secwatch.filing_event.v1"
accession: "0001650664-24-000081"
form_type: "8-K"
ticker: "EDIT"
cik: "0001650664"
company_name: "Editas Medicine, Inc."
filed_at: "2024-06-27T23:59:59+00:00"
generated_at: "2026-06-01T01:02:03.480726+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Editas Medicine director Akshay Vaishnaw resigns from Board effective June 30, 2024

## Summary
- Akshay Vaishnaw submitted resignation on June 27, 2024; effective June 30, 2024.
- Resignation not due to any disagreement with Company’s operations, policies, or practices.
- No replacement or additional board changes announced.

## SEC filing metadata
- accession: 0001650664-24-000081
- form_type: 8-K
- ticker: EDIT
- cik: 0001650664
- company_name: Editas Medicine, Inc.
- filed_at: 2024-06-27T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1650664/000165066424000081/0001650664-24-000081-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1650664/000165066424000081/edit-20240627.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001650664-24-000081
- JSON: https://secwatch.observer/filing/0001650664-24-000081.json
- Plain text: https://secwatch.observer/filing/0001650664-24-000081.txt

## Key facts
- Executive change
  Akshay Vaishnaw resigned as Director at Editas Medicine, Inc..
  - Action: resigned
  - Role: Director
  source text: On June 27, 2024, Akshay Vaishnaw informed the Board of Directors (the “Board”) of Editas Medicine, Inc. (the “Company”) of his resignation from the Board effective as of June 30, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1650664/000165066424000081/0001650664-24-000081-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
